The global hormone replacement therapy market size is predicted to reach USD 20.76 billion by 2026, exhibiting a CAGR of 6.0% during the forecast period. The increasing cases of hormone-related disorders in both men and women of different age groups will spur demand for hormone replacement therapy, which in turn, will boost the hormone replacement therapy market growth during the forecast period. In addition, the increasing prevalence of disorders such as growth deficiency, thyroid disorders, and others will create new sales opportunities for the market in the forthcoming years.
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this Hormone Replacement Therapy Market.
Please visit: https://www.fortunebusinessinsights.com/hormone-replacement-therapy-hrt-market-102543
The Report List the Main Companies in the Hormone Replacement Therapy Market
- Novo Nordisk A/S
- Pfizer Inc.
- AbbVie Inc.
- Merck KGaA
- Endo Pharmaceuticals Solutions Inc.
- Allergan
- Eli Lilly and Company
- Mithra Pharmaceuticals
Regional Analysis
High Rate Of Hormone Deficiency Disorders to Facilitate Growth in North America
The market in North America generated a revenue of USD 6.89 billion in 2018 and is expected to grow rapidly during the forecast period. The growth in the region is attributed to the rising prevalence of menopause disorders and growing incidence of hormone deficiency disorders. The increasing awareness regarding the therapies among patients will also support growth in the region. Europe is expected to account for a high share in the forthcoming years owing to the surge in hormonal disorders in women. The increasing cases of menopausal disorders and geriatric population suffering from the hypothyroidism will fuel demand for hormone replacement therapy in the region.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hormone-replacement-therapy-hrt-market-102543
Segmentation
By Therapy Type
- Estrogen and combinations replacement
- Thyroid Replacement
- Growth replacement
- Testosterone
By Indication
- Menopause
- Hypothyroidism
- Male hypogonadism
- Growth hormone deficiency
By Route of Administration
- Oral
- Transdermal
- Parenteral
By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies & Stores
- Online Pharmacies
By Geography
- North America (U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
- Latin America (Brazil, Mexico, and Rest of Latin America)
- Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/hormone-replacement-therapy-hrt-market-102543
Some major points from Table of Content:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Pipeline Analysis
- Key Industry Developments- Mergers, Acquisitions, and Collaborations
- Key Market Trends
- Global Hormone Replacement Therapy (HRT) Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Therapy Type
- Estrogen and combinations replacement
- Thyroid replacement
- Growth replacement
- Testosterone
- Market Analysis, Insights and Forecast – By Indication
- Menopause
- Hypothyroidism
- Male hypogonadism
- Growth hormone deficiency
- Market Analysis, Insights and Forecast – By Route of Administration
- Oral
- Transdermal
- Parenteral
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies & Stores
- Online Pharmacies
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- North America Hormone Replacement Therapy (HRT) Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis – By Therapy Type
- Estrogen and combinations replacement
- Thyroid replacement
- Growth replacement
- Testosterone
- Market Analysis – By Indication
- Menopause
- Hypothyroidism
- Male hypogonadism
- Growth hormone deficiency
- Market Analysis – By Route of Administration
- Oral
- Transdermal
- Parenteral
- Market Analysis – By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies & Stores
- Online Pharmacies
- Market Analysis – By Country
- S.
- Canada
- Europe Hormone Replacement Therapy (HRT) Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis – By Therapy Type
- Estrogen and combinations replacement
- Thyroid replacement
- Growth replacement
- Testosterone
- Market Analysis – By Indication
- Menopause
- Hypothyroidism
- Male hypogonadism
- Growth hormone deficiency
- Market Analysis – By Route of Administration
- Oral
- Transdermal
- Parenteral
- Market Analysis – By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies & Stores
- Online Pharmacies
- Market Analysis – By Country/ sub-region
- K.
- Germany
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
Continued…
